Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Transgene commences phase I trial for treatment of cervical cancer

Sep. 14, 1999

Maxamine treatment leads to tumor regression in preclinical model of prostate cancer

Sep. 14, 1999

LifeTime and Arkios enter oncology alliance

Sep. 13, 1999

Biomira revises collaboration with Chiron for Theratope vaccine

Sep. 7, 1999

Beta LT demonstrates positive results in initial human trials

Sep. 7, 1999

First patient enrolled in York Medical's cancer vaccine trial

Sep. 6, 1999

Immunomedics awarded four grants from the NIH for development of cancer therapies

Sep. 6, 1999

Maxamine combination treatment for AML effective in phase II studies

Sep. 6, 1999

FDA requests modifications to Bexxar BLA

Aug. 31, 1999

Herceptin approved in Canada for breast cancer therapy

Aug. 30, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...